Search Results - "Trepel, JB"

Refine Results
  1. 1

    The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy by BLAGOSKLONNY, M. V, FOJO, T, BHALLA, K. N, KIM, J-S, TREPEL, J. B, FIGG, W. D, RIVERA, Y, NECKERS, L. M

    Published in Leukemia (01-10-2001)
    “…The Bcr-Abl fusion protein drives leukemogenesis and can render leukemia cells resistant to conventional chemotherapy. Geldanamycin (GA), a drug which…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Abstract P2-11-10: Epigenetic immune modulation by entinostat in breast cancer: Correlative analysis of ENCORE 301 trial by Chumsri, S, Lee, M-J, Tomita, Y, Lee, S, Tomita, S, Cruickshank, S, Ordentlich, P, Trepel, JB

    Published in Cancer research (Chicago, Ill.) (15-02-2016)
    “…Background: Entinostat, a class I HDAC inhibitor (HDACi), has shown promising activity in ENCORE 301, a randomized, placebo-controlled, phase II trial of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275 by Camphausen, Kevin, Burgan, William, Cerra, Michael, Oswald, Kelli A., Trepel, Jane B., Lee, Min-Jung, Tofilon, Philip J.

    Published in Cancer research (Chicago, Ill.) (01-01-2004)
    “…Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation for cancer therapy. Because HDAC modulates chromatin structure and gene expression,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Impact of extracellular folate levels on global gene expression by Jhaveri, M S, Wagner, C, Trepel, J B

    Published in Molecular pharmacology (01-12-2001)
    “…Methylation of DNA is associated with gene silencing. DNA methylation uses S-adenosylmethionine (SAM) as the methyl donor and the formation of SAM requires a…”
    Get more information
    Journal Article
  8. 8

    Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment by Jhaveri, Mona S, Rait, Antonina S, Chung, Koong-Nah, Trepel, Jane B, Chang, Esther H

    Published in Molecular cancer therapeutics (01-12-2004)
    “…Folates are essential for cell survival and are required for numerous biochemical processes. The human α isoform folate receptor (αhFR) has a very high…”
    Get full text
    Journal Article
  9. 9

    Abrogation of p21 Expression by Flavopiridol Enhances Depsipeptide-Mediated Apoptosis in Malignant Pleural Mesothelioma Cells by NGUYEN, Dao M, SCHRUMP, William D, CHEN, G. Aaron, TSAI, Wilson, NGUYEN, Phuongmai, TREPEL, Jane B, SCHRUMP, David S

    Published in Clinical cancer research (01-03-2004)
    “…Purpose: Recent insights regarding the pathogenesis of malignant pleural mesothelioma (MPM) provide new opportunities for targeted molecular therapies for this…”
    Get full text
    Journal Article
  10. 10

    Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin by Chung, Eun Joo, Hwang, Sang-Gu, Nguyen, PhuongMai, Lee, Sunmin, Kim, Jung-Sik, Kim, Jin Woo, Henkart, Pierre A., Bottaro, Donald P., Soon, Lilian, Bonvini, Paolo, Lee, Su-Jae, Karp, Judith E., Oh, Ho Jung, Rubin, Jeffrey S., Trepel, Jane B.

    Published in Blood (01-08-2002)
    “…In epithelial cells β-catenin plays a critical role as a component of the cell-cell adhesion apparatus and as a coactivator of the TCF/LEF (T-cell…”
    Get full text
    Journal Article
  11. 11

    Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models by Shibata, Masa-Aki, Kavanaugh, Claudine, Shibata, Eiko, Abe, Hideaki, Nguyen, PhuongMai, Otsuki, Yoshinori, Trepel, Jane B., Green, Jeffrey E.

    Published in Carcinogenesis (New York) (01-03-2003)
    “…The effects of lovastatin, a potent inhibitor of HMG CoA reductase, on experimental mammary and prostate oncogenesis, were studied in vitro and in vivo…”
    Get full text
    Journal Article
  12. 12

    DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation by Sun, Lunching, Huang, Lei, Nguyen, Phuongmai, Bisht, Kheem S, Bar-Sela, Gil, Ho, Allen S, Bradbury, C Matthew, Yu, Wenqiang, Cui, Hengmi, Lee, Sunmin, Trepel, Jane B, Feinberg, Andrew P, Gius, David

    Published in Cancer research (Chicago, Ill.) (15-04-2008)
    “…In a previous genomic analysis, using somatic methyltransferase (DNMT) knockout cells, we showed that hypomethylation decreased the expression of as many genes…”
    Get full text
    Journal Article
  13. 13

    DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells by TRAPANI, V, PATEL, V, LEONG, C.-O, CIOLINO, H. P, YEH, G. C, HOSE, C, TREPEL, J. B, STEVENS, M. F. G, SAUSVILLE, E. A, LOAIZA-PEREZ, A. I

    Published in British journal of cancer (24-02-2003)
    “…The fluorinated benzothiazole analogue 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is a novel agent with potent and selective…”
    Get full text
    Journal Article
  14. 14

    Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells by Loaiza-Pérez, Andrea I, Kenney, Susan, Boswell, Jamie, Hollingshead, Melinda, Alley, Michael C, Hose, Curtis, Ciolino, Henry P, Yeh, Grace C, Trepel, Jane B, Vistica, David T, Sausville, Edward A

    Published in Molecular cancer therapeutics (01-06-2004)
    “…Aminoflavone (4H-1-benzopyran-4-one, 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl; NSC 686288) demonstrates differential antiproliferative activity…”
    Get full text
    Journal Article
  15. 15

    A phase II study of perifosine in androgen independent prostate cancer by Posadas, Edwin M., Gulley, James L., Arlen, Philip M., Trout, Alisa, Parnes, Howard L., Wright, John, Lee, Min-Jung, Chung, Eun Joo, Trepel, Jane B., Sparreboom, Alex, Chen, Clara, Jones, Elizabeth, Steinberg, Seth M., Daniels, Andrew, Figg, II, William, Dahut, William L.

    Published in Cancer biology & therapy (01-10-2005)
    “…OBJECTIVES: Perifosine is an alkylphospholipid that has exhibited broad antineoplastic activity in preclinical studies. The primary objective of this study was…”
    Get full text
    Journal Article
  16. 16

    Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling by MOUSSES, Spyro, WAGNER, Urs, YIDONG CHEN, KIM, J. W, BUBENDORF, Lukas, BITTNER, Michael, PRETLOW, Thomas, ELKAHLOUN, Abdel G, TREPEL, Jane B, KALLIONIEMI, Olli-P

    Published in Oncogene (11-10-2001)
    “…Androgen deprivation therapy for advanced prostate cancer is often effective, but not curative. Molecular pathways mediating the therapeutic response and those…”
    Get full text
    Journal Article
  17. 17

    Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole by Loaiza-Pérez, Andrea I, Trapani, Valentina, Hose, Curtis, Singh, Sheo S, Trepel, Jane B, Stevens, Malcolm F G, Bradshaw, Tracey D, Sausville, Edward A

    Published in Molecular pharmacology (01-01-2002)
    “…2-(4-Amino-3-methylphenyl) benzothiazole (NSC 674495; DF 203) demonstrates drug uptake and metabolism by tumor cells sensitive to the antiproliferative…”
    Get more information
    Journal Article
  18. 18

    MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type II receptor expression in human breast cancer cells by BYOUNG ICK LEE, SEOK HEE PARK, JIN WOO KIM, SAUSVILLE, Edward A, HEUNG TAE KIM, NAKANISHI, Osamu, TREPEL, Jane B, KIM, Seong-Jin

    Published in Cancer research (Chicago, Ill.) (01-02-2001)
    “…Transcriptional repression of the transforming growth factor (TGF)-1P type II receptor (TPRII) gene appears to be a major mechanism to inactivate TGF-beta…”
    Get full text
    Journal Article
  19. 19

    Protease inhibitor-induced apoptosis : accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition by AN, W. G, HWANG, S.-G, TREPEL, J. B, BLAGOSKLONNY, M. V

    Published in Leukemia (01-07-2000)
    “…Inhibitors of proteases are currently emerging as a potential anti-cancer modality. Nonselective protease inhibitors are cytotoxic to leukemia and cancer cell…”
    Get full text
    Journal Article
  20. 20

    Sequential 5-Aza 2′-deoxycytidine depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells by STEINER, Federico A, HONG, Julie A, TREPEL, Jane B, SCHRUMP, David S, FISCHETTE, Maria R, BEER, David G, GUO, Zong-Sheng, CHEN, G. Aaron, WEISER, Todd S, KASSIS, Edmund S, NGUYEN, Dao M, LEE, Sunmin

    Published in Oncogene (31-03-2005)
    “…cDNA arrays were used to examine gene induction in CALU-6 and H460 lung cancer cells mediated by sequential 5-aza 2'-deoxycytidine (DAC)/depsipeptide FK228…”
    Get full text
    Journal Article